![Gwen Melincoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gwen Melincoff
Director/Board Member at
GAIN THERAPEUTICS, INC.
Net worth: 17 775 $ as of 2026-07-30
Profile
Gwen A. Melincoff currently serves as Independent Director at Protalix Biotherapeutics, Inc. since 2019, Managing Director at Vodia Capital LLC, and Independent Director at Gain Therapeutics, Inc. since 2021.
Former roles include Independent Director at Collegium Pharmaceutical, Inc. from 2017 to 2025, Director at Naurex, Inc., Director at ArmaGen, Inc., Independent Director at Photocure ASA from 2017 to 2020, Director at DBV Technologies SA, Independent Director at Kamada Ltd. from 2017 to 2018, Director at AM-Pharma BV, Director at Enterome SA, Director at PROMETHERA Biosciences SA, Independent Director at Tobira Therapeutics, Inc. from 2014 to 2016, Independent Director at Soleno Therapeutics, Inc. from 2019 to 2024, Vice President-Business Development at Adolor Corp.
from 1999 to 2004, Senior Vice President-Corporate Development at Shire Plc, Vice President-Business Development at BTG International, Inc. from 2014 to 2016, and Senior Vice President-Business Development at Shire Pharmaceuticals, Inc. from 2004 to 2013.
Education includes undergraduate studies at George Washington University and graduate studies at The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-29 | 7,500 ( 0.01% ) | 17 775 $ | 2026-07-30 | |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company -.--% | 2026-05-31 | 0 ( -.--% ) | - $ | 2026-07-30 |
| 2026-07-14 | 0 ( -.--% ) | - $ | 2026-07-30 |
Gwen Melincoff active positions
| Companies | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 2019-11-30 |
| GAIN THERAPEUTICS, INC. | Director/Board Member | 2020-12-31 |
Vodia Capital LLC
 Vodia Capital LLC Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | - |
Former positions of Gwen Melincoff
| Companies | Position | End |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2025-05-14 |
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 2024-06-05 |
| PHOTOCURE ASA | Director/Board Member | 2020-06-09 |
| KAMADA LTD. | Director/Board Member | 2018-12-19 |
| TOBIRA THERAPEUTICS INC | Director/Board Member | 2016-10-30 |
Training of Gwen Melincoff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Photocure ASA
 Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
Vodia Capital LLC
Vodia Capital LLC Investment ManagersFinance Provides investment advisory services | Finance |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Gwen Melincoff
